Our understanding of bone and soft tissue tumors has thoroughly evolved as a consequence of modern molecular techniques. DNA and RNA sequencing methods play an important diagnostic and therapeutic role in sarcoma pathology. Herein, we discuss current guidelines and best practices for molecular testing in bone and soft tissue tumors.
Citations
Citations to this article as recorded by
RB1: governor of the cell cycle in health and disease—a primer for the practising pathologist Fleur Cordier, David Creytens Journal of Clinical Pathology.2024; 77(7): 435. CrossRef